FIELD: medicine; pharmaceuticals.
SUBSTANCE: invention relates to medicine, specifically to a packaged pharmaceutical product comprising a stable solid pharmaceutical composition and a moisture-impermeable package, wherein said composition contains a homogeneous mixture of a base of amlodipine or amlodipine besylate and bisoprolol fumarate and pharmaceutically acceptable excipients, is packaged in said moisture-impermeable package and further contains less than 0.5 % of weight of active ingredients of compound of formula
and where said moisture-proof package is a blister pack of cold molding from composite foil OPA/AL/PVC (foil of oriented polyamide/aluminum/polyvinyl chloride), coated with aluminum membrane foil.
EFFECT: invention provides a packaged pharmaceutical product wherein the amount of impurities does not exceed ½ % during preparation or during storage until expiry of the composition for at least two years.
8 cl, 2 ex, 2 tbl
Title | Year | Author | Number |
---|---|---|---|
STABLE COMBINED PHARMACEUTICAL COMPOSITION | 2009 |
|
RU2549437C2 |
PHARMACEUTICAL COMPOSITION CONTAINING BETA-BLOCKER AND ANGIOTENSIN-CONVERTING ENZYME INHIBITOR | 2015 |
|
RU2702362C2 |
THERAPEUTIC COMBINATION OF AMLODIPINE AND BENAZEPRIL/BENAZEPRILATE | 2001 |
|
RU2292206C2 |
COMPOSITION INCLUDING AMLODIPINE AND LOSARTAN HAVING IMPROVED STABILITY | 2013 |
|
RU2628538C2 |
COMPOSITIONS AND METHODS OF ACTIVE PHARMACEUTICAL INGREDIENT STABILISATION | 2005 |
|
RU2391115C2 |
PHARMACEUTICAL COMPOSITION CONTAINING BETA-BLOCKER, CONVERTING ENZYME INHIBITOR AND HYPOTENSIVE AGENT OR NSAID | 2017 |
|
RU2756320C2 |
STABLE PHARMACEUTICAL PREPARATION CONTAINING AMLODIPINE BENZYLATE AND ATENOLOL | 1998 |
|
RU2188636C2 |
METHOD OF TREATING CARDIOVASCULAR DISEASES | 2012 |
|
RU2570752C2 |
AMLODIPINE GENTISATE AND ITS OBTAINING METHOD | 2004 |
|
RU2330843C2 |
SOLID PHARMACEUTICAL COMPOSITION CONTAINING AMLODIPINE AND LOSARTAN | 2015 |
|
RU2698703C2 |
Authors
Dates
2019-05-13—Published
2009-09-30—Filed